ATE378404T1 - Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon - Google Patents

Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon

Info

Publication number
ATE378404T1
ATE378404T1 AT02762445T AT02762445T ATE378404T1 AT E378404 T1 ATE378404 T1 AT E378404T1 AT 02762445 T AT02762445 T AT 02762445T AT 02762445 T AT02762445 T AT 02762445T AT E378404 T1 ATE378404 T1 AT E378404T1
Authority
AT
Austria
Prior art keywords
oxidative stress
kit
implementing
same
risk factor
Prior art date
Application number
AT02762445T
Other languages
English (en)
Inventor
Joel Pincemail
Jacques Piette
Daniel Marechal
Original Assignee
Probiox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiox Sa filed Critical Probiox Sa
Application granted granted Critical
Publication of ATE378404T1 publication Critical patent/ATE378404T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)
AT02762445T 2001-08-14 2002-08-13 Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon ATE378404T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE2001/0545A BE1014949A3 (fr) 2001-08-14 2001-08-14 Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.

Publications (1)

Publication Number Publication Date
ATE378404T1 true ATE378404T1 (de) 2007-11-15

Family

ID=3897081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02762445T ATE378404T1 (de) 2001-08-14 2002-08-13 Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon

Country Status (7)

Country Link
US (1) US7288374B2 (de)
EP (1) EP1423518B1 (de)
AT (1) ATE378404T1 (de)
BE (1) BE1014949A3 (de)
DE (1) DE60223561T2 (de)
ES (1) ES2296987T3 (de)
WO (1) WO2003016527A2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
GB0225885D0 (en) * 2002-11-06 2002-12-11 Isis Innovation Quantifying exposure to stress
WO2004046729A2 (en) * 2002-11-21 2004-06-03 The University Of Leicester Bodily fluid markers of tissue hypoxia
WO2005020984A2 (en) * 2003-08-29 2005-03-10 Aaipharma Inc. Method of reducing the risk of oxidative stress
GB0409153D0 (en) * 2004-04-23 2004-05-26 Randox Lab Ltd Method of diagnosis
ES2315034B1 (es) * 2004-07-02 2009-12-30 Laboratorios Indas, S.A. Proteina de choque termico 27 (hsp-27) como marcador de enfermedad cardiovascular.
WO2006118988A2 (en) * 2005-04-29 2006-11-09 University Of Tennessee Research Foundation Cellular biomarker antioxidant assay and uses thereof
FR2894030B1 (fr) * 2005-11-30 2008-07-04 Michel Brack Procede de determination d'un score representatif du stress oxydatif d'un patient, sur une echelle de 0 a 10
WO2007143066A2 (en) * 2006-05-31 2007-12-13 Health Research Inc. Method for predicting susceptibility to radiation pneumonitis
WO2008019060A2 (en) * 2006-08-03 2008-02-14 U.S. Department Of Veterans Affairs Office Of General Counsel-Psg Iv (024) Method for predicting onset/risk of atrial fibrillation (af)
FR2923609A1 (fr) 2007-11-13 2009-05-15 Thierry Patrice Test pour la mesure de la resistance au stress oxydant et ses applications
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
WO2012094580A2 (en) * 2011-01-07 2012-07-12 High Point Pharmaceuticals, Llc Compounds that modulate oxidative stress
WO2012162260A2 (en) 2011-05-21 2012-11-29 Kdt, Llc. Transgenic biosensors
ES2657552T3 (es) 2011-09-08 2018-03-05 Yeda Research And Development Co. Ltd. Nuevos biomarcadores de riesgo para el cáncer de pulmón
RU2534821C2 (ru) * 2012-05-18 2014-12-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Способ диагностики окислительного стресса измерением экспрессии кислородчувствительных генов (варианты)
WO2014093828A2 (en) 2012-12-14 2014-06-19 The Procter & Gamble Company Antiperspirant and deodorant compositions
WO2014100361A1 (en) * 2012-12-19 2014-06-26 The Johns Hopkins University Protection from oxidative damage by gene transfer by glutamate cysteine ligase and glutathione synthase
EP2972324B1 (de) * 2013-03-15 2020-04-22 The Procter and Gamble Company Nicht-invasives verfahren zur diagnose von kopfschuppen
RU2545900C2 (ru) * 2013-05-07 2015-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук Способ диагностики апоптоза лимфоцитов
RU2540500C2 (ru) * 2013-05-07 2015-02-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук Способ прогнозирования ранней стадии апоптоза
US9995758B1 (en) * 2014-10-31 2018-06-12 Western Autotroph Company LLC Methods and systems for controlling oxidative stress in humans and animals
US12667548B2 (en) 2014-11-07 2026-06-30 Nacuity Pharmaceuticals, Inc. Treatment of retinitis pigmentosa and retinitis pigmentosa associated with Usher Syndrome with N-acetylcysteine amide
US12472157B2 (en) 2014-11-07 2025-11-18 Nacuity Pharmaceuticals, Inc. Treatment of retinitis pigmentosa with n-acetylcysteine amide
US11268964B2 (en) 2014-11-11 2022-03-08 The Johns Hopkins University Biomarkers useful in the treatment of subjects having diseases of the eye
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US11091433B2 (en) 2017-09-20 2021-08-17 Nacuity Pharmaceutials, Inc. Method for preparation of N-acetyl cysteine amide and derivatives thereof
US11548851B2 (en) 2017-09-20 2023-01-10 Nacuity Pharmaceuticals, Inc. Method for preparation of n-acetyl cysteine amide and derivatives thereof
US12662449B2 (en) 2017-09-20 2026-06-23 Nacuity Pharmaceuticals, Inc. Method for preparation of N-acetyl cysteine amide and derivatives thereof
CA3079196C (en) 2017-09-20 2021-05-18 Nacuity Pharmaceuticals, Inc. Method for preparation of n-acetyl cysteine amide and derivatives thereof
US20190135741A1 (en) 2017-11-09 2019-05-09 Nacuity Pharmaceuticals, Inc. Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
CN109797133A (zh) * 2019-01-09 2019-05-24 珠海金肽生物科技有限公司 多潜能细胞培养组合物及制备方法和应用
WO2020146660A1 (en) 2019-01-11 2020-07-16 Nacuity Pharmaceuticals, Inc. N-acetylcysteine amide (naca) and (2r,2r')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (dinaca) for prevention and treatment of radiation pneumonitis and treatment of pulmonary function in cystic fibrosis
AU2020206139A1 (en) 2019-01-11 2021-07-29 Nacuity Pharmaceuticals, Inc. Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with N-acetylicysteine amide (NACA) or 2R,2R')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (diNACA)
JP7631200B2 (ja) 2019-01-11 2025-02-18 ナキュイティ ファーマシューティカルズ， インク． 放射線皮膚炎の予防及び治療、並びに皮膚ライトニング、皮膚ホワイトニング、並びに皮膚改善のためのｎ－アセチルシステインアミド（ｎａｃａ）及び（２ｒ，２ｒ’）－３，３’－ジスルファンジイルビス（２－アセトアミドプロパンアミド）（ｄｉｎａｃａ）
CN112684020B (zh) * 2020-12-01 2023-12-29 哈尔滨医科大学 一种用于评价个体锌营养状态的生物标志物及其应用
DE102023124443A1 (de) 2023-09-11 2025-03-27 Albert-Ludwigs-Universität Freiburg, Körperschaft des öffentlichen Rechts Vorrichtung zur Modifikation von Blut

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2534631B2 (ja) * 1986-01-17 1996-09-18 プリベンティブ メディシン インスティテュート Ｄｎａが関連する病気にかかり易い体質または該病気に対する感受性を測定するための試験
CA2271068A1 (en) * 1996-11-12 1998-05-22 Zehava Grosman Method for identifying translationally regulated genes
JP2002504812A (ja) * 1997-05-21 2002-02-12 クローンテック ラボラトリーズ，インコーポレイテッド 核酸アレイ
AU3981799A (en) * 1998-05-11 1999-11-29 Quark Biotech, Inc. Method for identifying genes
EP1082463B1 (de) * 1998-05-15 2007-01-03 Quark Biotech, Inc. Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung.
US6569683B1 (en) * 1998-05-29 2003-05-27 Nikken Foods Co., Ltd. Use of oxidative stress diagnostic plot as a health indicator for assessing oxidative stress and its control in humans
WO2000009750A1 (en) * 1998-08-14 2000-02-24 The Trustees Of The University Of Pennsylvania Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression
WO2000065095A2 (en) * 1999-04-23 2000-11-02 Clontech Laboratories, Inc. Methods and compositions for performing array based hybridization assays
US6607885B1 (en) * 1999-10-15 2003-08-19 E. I. Du Pont De Nemours And Company Method for high-density microarray medicated gene expression profiling
WO2001032802A1 (en) 1999-10-29 2001-05-10 The Cleveland Clinic Foundation Method and apparatus for predicting male infertility
AU2872501A (en) * 1999-12-21 2001-07-03 Eirx Therapeutics Limited Screening method
US6541265B2 (en) * 2001-05-09 2003-04-01 University Of Florida Method and system to test a substance for inflammatory or oxidant properties
WO2003064994A2 (en) * 2002-01-29 2003-08-07 Talton James D Methods of collecting and analyzing human breath

Also Published As

Publication number Publication date
US20050112572A1 (en) 2005-05-26
WO2003016527A2 (en) 2003-02-27
DE60223561T2 (de) 2008-05-29
BE1014949A3 (fr) 2004-07-06
US7288374B2 (en) 2007-10-30
WO2003016527A3 (en) 2003-12-31
EP1423518A2 (de) 2004-06-02
DE60223561D1 (de) 2007-12-27
ES2296987T3 (es) 2008-05-01
EP1423518B1 (de) 2007-11-14

Similar Documents

Publication Publication Date Title
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
WO2004055519A3 (en) Specific markers for pancreatic cancer
DE602005013670D1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
ATE232559T1 (de) Verfahren zur signalverstärkung
DE60115314D1 (de) Verfahren für die Auswertung von Bildern zur Defekterkennung
DE60216389D1 (de) Verfahren zur zerstörungsfreien Prüfung
ATE540319T1 (de) Verfahren für die bestimmung von fk506
DE69836888D1 (de) Verfahren für Fluoreszenzerkennungstest
DE59912512D1 (de) Messanordnung zur Erfassung von Dimensionen von Prüflingen, vorzugsweise von Hohlkörpern, insbesondere von Bohrungen in Werkstücken, sowie Verfahren zur Messung solcher Dimensionen
DE60305044D1 (de) Verfahren und vorrichtung zur bestimmung von bor bei der röntgenfluoreszenz-spektroskopie
DE602004023824D1 (de) Verfahren zum direkten nachweis einzelner methotrexatmetabolite
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE476525T1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DE50203510D1 (de) Verfahren zur erkennung und identifizierung von objekten
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
FI20040255A7 (fi) Menetelmä pre-eklampsian riskin havaitsemiseksi
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
DE10393421D2 (de) Verfahren zur Anreicherung und zum Nachweis von pathologisch veränderten Prion-Proteinen (PRPSC)
DE60129015D1 (de) Verfahren zur erkennung von entzündungen und entzündungsbedingungen
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE482283T1 (de) Verfahren, biosensoren und kits zum nachweis und zur identifizierung von pilzen
DE10360844B4 (de) Verfahren zum Nachweis und zur Entfernung von Endotoxin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties